We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in oncology and obesity.

The firm aims to deliver as much as $4 billion in 2024 cost savings. Cramer’s remarks surrounded Dr. Bourla’s relationship and potential meeting with President-elect Trump: “Dr. Bourla ...

Stan Polovets highlights the Genesis Prize's role in celebrating Jewish excellence and driving global impact through ...

Artbio, a clinical-stage radiopharmaceutical company, named Johnson & Johnson alum Margaret Yu as chief medical officer. Saisei Ventures tapped Dr. Sven Kili as partner. OSE Immunotherapeutics ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Bourla is a doctor of veterinary medicine and ... In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI.

(JTA) — Drawing a line between its mission of Holocaust remembrance and the ravages inflicted by the coronavirus pandemic, the March of the Living honored Dr. Anthony Fauci with an award for ...

"Dr Boshoff is the ideal leader to propel ... medicines with blockbuster potential," said chief executive Albert Bourla. Bourla has been fighting off criticism of the leadership and strategy ...